{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:57:32Z","timestamp":1770501452472,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.clinthera.2006.01.008","type":"journal-article","created":{"date-parts":[[2006,2,19]],"date-time":"2006-02-19T07:15:17Z","timestamp":1140333317000},"page":"73-85","source":"Crossref","is-referenced-by-count":32,"title":["Efficacy and tolerability of fluticasone propionate\/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study"],"prefix":"10.1016","volume":"28","author":[{"given":"Robert A.","family":"Nathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Rooklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne","family":"Schoaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ellsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"House","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dorinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2006.01.008_bib1","author":"National Asthma Education and Prevention Program","year":"2002","journal-title":"Executive Summary of the NAEPP Expert Panel Report. Guidelines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002"},{"key":"10.1016\/j.clinthera.2006.01.008_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1081-1206(10)63288-7","article-title":"The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma","volume":"82","author":"Condemi","year":"1999","journal-title":"Ann Allery Asthma Immunol"},{"key":"10.1016\/j.clinthera.2006.01.008_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(94)92996-3","article-title":"Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid","volume":"344","author":"Greening","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2006.01.008_bib4","first-page":"173","article-title":"Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases","volume":"20","author":"Murray","year":"1999"},{"key":"10.1016\/j.clinthera.2006.01.008_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1081-1206(10)62606-3","article-title":"Inhaled salmeterol and fluticasone: A study comparing monotherapy and combination therapy in asthma","volume":"82","author":"Pearlman","year":"1999","journal-title":"Ann Allery Asthma Immunol"},{"key":"10.1016\/j.clinthera.2006.01.008_bib6","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bmj.320.7246.1368","article-title":"Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)","volume":"320","author":"Shrewsbury","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2006.01.008_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/thx.54.3.207","article-title":"Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma","volume":"54","author":"van Noord","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.clinthera.2006.01.008_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/02770909909065153","article-title":"Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids","volume":"36","author":"Vermetten","year":"1999","journal-title":"J Asthma"},{"key":"10.1016\/j.clinthera.2006.01.008_bib9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1164\/ajrccm.153.5.8630590","article-title":"Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids","volume":"153","author":"Woolcock","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinthera.2006.01.008_bib10","first-page":"S77","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease","volume":"152","author":"American Thoracic Society","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 6","key":"10.1016\/j.clinthera.2006.01.008_bib11","first-page":"5","article-title":"Standardization of lung function tests","volume":"6","author":"Report of the Working Party of the European Community for Coal and Steel","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clinthera.2006.01.008_bib12","series-title":"Pulmonary Function Testing in Children: Techniques and Standards","author":"Polgar","year":"1971"},{"key":"10.1016\/j.clinthera.2006.01.008_bib13","first-page":"626","article-title":"Reference values for lung function tests","volume":"34","author":"Crapo","year":"1989","journal-title":"Respir Care"},{"key":"10.1016\/j.clinthera.2006.01.008_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1081\/JAS-200038368","article-title":"Efficacy and safety of fluticasone propionate\/salmeterol HFA 134A M DI in patients with mild-to-moderate persistent asthma","volume":"41","author":"Pearlman","year":"2004","journal-title":"J Asthma"},{"key":"10.1016\/j.clinthera.2006.01.008_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/ajrccm.161.2.9905091","article-title":"Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma","volume":"161","author":"Shapiro","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clinthera.2006.01.008_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/009286159903300218","article-title":"The evaluation of multiple clinical endpoints, with application to asthma","volume":"33","author":"Neuhauser","year":"1999","journal-title":"Drug Inf J"},{"key":"10.1016\/j.clinthera.2006.01.008_bib17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0954-6111(05)80060-5","article-title":"Metered-dose inhalers and CFCs: What respiratory physicians need to know","volume":"88","author":"Partridge","year":"1994","journal-title":"Respir Med"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2006.01.008_bib18","first-page":"55","article-title":"Continuing patient care with metered-dose inhalers","volume":"8","author":"Woodcock","year":"1995","journal-title":"J Aerosol Med"},{"key":"10.1016\/j.clinthera.2006.01.008_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(94)92770-7","article-title":"CFCs and inhalers","volume":"344","author":"Woodcock","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2006.01.008_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF02893807","article-title":"Compliance with inhaled medications: The relationship between diary and electronic monitor","volume":"20","author":"Berg","year":"1998","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.clinthera.2006.01.008_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1081-1206(10)63528-4","article-title":"Efficacy and safety of fluticasone propionate 44 microg\/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose in haler as an initial asthma maintenance treatment","volume":"91","author":"Nelson","year":"2003","journal-title":"Ann Allery Asthma Immunol"},{"key":"10.1016\/j.clinthera.2006.01.008_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2003.10.011","article-title":"Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies","volume":"113","author":"Stoloff","year":"2004","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806000221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806000221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T20:39:14Z","timestamp":1555447154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291806000221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0149291806000221"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2006.01.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}